Joining a Medicare Advantage plan can feel like a one-way decision, especially once a retiree hears how medical underwriting can lock people out of the private Medigap market later in life. Federal rules soften that risk during the first year: a person who tries Medicare Advantage and decides it is not working can, within a defined window, switch back to Original Medicare and buy a Medigap policy without an insurer being allowed to deny coverage or charge more because of a health condition.
The trial-right window explained
The protection applies in two related situations. Someone who drops an existing Medigap policy to join a Medicare Advantage plan for the first time gets a single 12-month trial-right period during which, if the same insurance company still sells that same Medigap policy, they can get it back on a guaranteed-issue basis after returning to Original Medicare. Separately, someone who joins a Medicare Advantage plan the moment they first become eligible for Medicare at 65 can buy certain Medigap policies sold by an insurance company in their state on a guaranteed-issue basis if they switch to Original Medicare within the first year of that Medicare Advantage enrollment. Both paths exist specifically so that trying Medicare Advantage first does not permanently close the door on Medigap.
If the exact policy a person previously held is no longer sold, federal guaranteed-issue rights still apply to certain other Medigap plans, though the specific options available depend on state law and on whether the person became eligible for Medicare on or after January 1, 2020, since that date affects which standardized plan letters are available to newly eligible beneficiaries.
Free retirement updates: Miss an enrollment or claim deadline and the money may be gone for good. The free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
What guaranteed issue actually protects against
Outside of specific protected windows like this one, Medigap insurers in most states are allowed to use medical underwriting, meaning they can review an applicant’s health history and either charge a higher premium or deny coverage entirely based on pre-existing conditions. A guaranteed-issue right removes that discretion: when it applies, the insurance company can’t use any medical answers to deny a policy or change its price. For someone who developed a chronic condition during their first year in Medicare Advantage, that protection can be the difference between affordable supplemental coverage and being effectively priced out of the Medigap market altogether.
The practical value of the trial right is highest for exactly the people most likely to need it: those who joined Medicare Advantage in reasonably good health, developed a new diagnosis during that first year, and then discovered their plan’s network or cost-sharing structure did not fit their new medical needs. Without the trial right, that same person trying to buy Medigap after a new diagnosis could face medical underwriting in states that permit it, potentially resulting in a much higher premium or a denial.
The clock does not wait for a decision
The 12-month trial-right period is tied to the date of Medicare Advantage enrollment, not to when a person realizes the plan is not a good fit, which means indecision itself carries a cost. Someone who spends eight months weighing whether to switch has effectively four months left to act on a guaranteed-issue basis, not a fresh 12-month clock starting from the day they finally decide. Because the underlying enrollment mechanics involve both dropping the Medicare Advantage plan and applying for a Medigap policy, starting that process well before the 12-month mark closes gives more room to work through paperwork, compare available Medigap plans in a given state, and address any complications before the guaranteed-issue protection expires.
A person who lets the window close without acting is not permanently barred from ever getting Medigap, but they lose the guarantee, and depending on the state, may face medical underwriting on any future application. Since the protection exists precisely to make it lower-risk to try Medicare Advantage, treating the 12-month mark as a hard deadline, rather than a rough guideline, preserves the safety net the rule was designed to provide.
Why this matters most during open enrollment season
Every fall’s Medicare Open Enrollment Period brings a wave of new Medicare Advantage sign-ups, many from people switching away from Original Medicare and Medigap for the first time. The trial right is the built-in safety valve for that decision, and it is worth understanding before enrolling, not after a plan’s network or costs turn out to be a poor fit. A retiree weighing a switch to Medicare Advantage for the first time can make that decision with more confidence knowing the door back to Original Medicare and guaranteed Medigap coverage stays open for a full year, provided they act before that year runs out.
None of this changes the underlying tradeoffs between the two paths through Medicare. Medicare Advantage plans typically carry lower or no monthly premium beyond Part B, bundle extra benefits like dental or vision, and cap annual out-of-pocket spending, while Original Medicare paired with Medigap generally offers broader provider access at the cost of separate premiums for the Medigap policy and, usually, a standalone Part D drug plan. The trial right does not make one path objectively better than the other; it simply ensures that choosing Medicare Advantage first does not foreclose the option to change course once a person has real experience with the plan rather than a projection of how it might work.
This article was produced with the assistance of AI and reviewed by The Financial Wire editorial team.
More Financial Reading
- Bank statements: how long to keep them and when to toss them
- Adding someone to your bank account: tax traps and smart moves



